Press releases
These press releases are intended for journalists and analysts/investors.
-
Research shows hay fever nothing to sneeze at
Interior design guru Darren Palmer shares his hay fever story
-
GSK Hepatitis B vaccine availability
We are currently experiencing a supply constraint of Twinrix Adult (combined hepatitis A and B vaccine) due to a precautionary disruption
-
What Aussie parents need to know about meningococcal disease
Whilst 93 percent of Australian parents believe that they know what meningococcal disease is, on average nearly a third of Australian parent
-
The three letters making Australian men disappear
There’s a disease affecting one in three Australian men over 50
-
GSK confirms that Bexsero (meningococcal B vaccine) will be available for purchase in Australia next week
GSK has increased supply by an additional 200,000 doses of Bexsero (meningococcal B vaccine) which can be ordered
-
Access to Breo Ellipta for respiratory patients on the PBS is unchanged
Breo Ellipta PBS listing updated to recognise fluticasone furoate as a distinct medicine from fluticasone propionate from 1 June 2017
-
GSK transfers Ultiva to Aspen in Australia
GlaxoSmithKline Australia Pty Ltd (GSK) is formally transferring Ultiva (remifentanil), an anaesthetic, to Aspen Pharmacare Australia
-
Bexsero (meningococcal B) vaccine availability
While we increased supply of Bexsero (meningococcal B) vaccine significantly this year, it still isn’t meeting demand and we have been
-
GSK welcomes Medicines Australia strategic agreement
GlaxoSmithKline (GSK) Australia welcomes the Government’s commitment to the Medicines Australia strategic agreement
-
Collaboration and mentorship prove winning formula for manufacturing
Collaboration between business and education is critical for a strong Australian medicine manufacturing industry
-
GSK Australia Reports 2016 results to ASIC
GlaxoSmithKline (GSK) Australia has reported its 2016 results to the Australian Securities and Investment Commission (ASIC)
-
Statement on arachnoiditis and myelograms
GSK has the utmost sympathy for the people who are afflicted by arachnoiditis. It can be a very debilitating and painful condition
-
GSK responds to Cyclone Debbie
GSK has responded to the Queensland Cyclone Debbie emergency relief by providing two pharmacies in Bowen and Airlie Beach with a donation
-
Availability of Menveo (meningococcal ACWY vaccine)
GSK is experiencing a short-term supply constraint of Menveo® in Australia due to a recent increase in notifications of the meningococcal
-
GSK discloses $28,375 in payments to HCPs
GSK stopped paying healthcare professionals to speak about our prescription medicines and vaccines on 1 January 2016
-
GSK increases supply of Meningococcal B vaccine
Recently there has been a global increase in demand for Bexsero (meningococcal B) vaccine which is reflected in Australia as well
-
New research shows Australians aren’t taking ageing lying down
Over 50s keep up with active-wear obsessed millennials on the activity stakes*
-
New treatment option available January 1 2017 for patients with a form of severe asthma
First therapy approved for severe refractory eosinophilic asthma to be listed on the PBS
-
Santa’s prostate nightmare urges Australian men to act
What would happen to Christmas if Santa suffered prostate issues?
-
GSK invests to support female technology entrepreneurs
GSK Australia announced today that it will support BlueChilli’s ‘SheStarts’
